Leukemia & Lymphoma
Journal Abbreviation: LEUKEMIA LYMPHOMA
ISSN: 1042-8194
eISSN: 1029-2403
Publisher: Informa Healthcare
Publications (19)
Additional benefits of telomere length (TL) measurements in chronic lymphocytic leukemia (2019)
Kaifie A, Schikowsky C, Vasko T, Kraus T, Brümmendorf TH, Ziegler P
Journal article
Asparaginase activities during intensified treatment with pegylated E. coli asparaginase in adults with newly-diagnosed acute lymphoblastic leukemia (2019)
Lanvers-Kaminsky C, Niemann A, Eveslage M, Beck J, Köhnke T, Martin S, de Wit M, et al.
Journal article
Navigating the changing multiple myeloma treatment landscape: clinical practice patterns of MM patients treated in- and outside German DSMM study group trials* (2018)
Gengenbach L, Reinhardt H, Ihorst G, Ajayi S, Dold SM, Koehler M, Einsele H, et al.
Journal article
Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCL (2018)
Frick M, Bettstetter M, Bertz S, Schwarz-Furlan S, Hartmann A, Richter T, Lenze D, et al.
Journal article
Analysis of dendritic cell subpopulations in follicular lymphoma with respect to the tumor immune microenvironment (2016)
Chevalier N, Mueller M, Mougiakakos D, Ihorst G, Marks R, Schmitt-Graeff A, Veelken H
Journal article
Up-regulated MSI2 is associated with more aggressive chronic myeloid leukemia (2015)
Kaeda J, Ringel F, Oberender C, Mills K, Quintarelli C, Pane F, Koschmieder S, et al.
Journal article, Original article
Feasibility of VECOPA, a dose-intensive chemotherapy regimen for children and adolescents with intermediate and advanced stage Hodgkin lymphoma: results of the GPOH-HD-2002/VECOPA pilot trial (2015)
Mauz-Koerholz C, Hasenclever D, Holzendorf V, Bernstaedt M, Juergens H, Burdach S, Eggert A, et al.
Journal article
Response monitoring of infant acute myeloid leukemia treatment by quantification of the tumor specific MLL-FNBP1 fusion gene (2015)
Krumbholz M, Jung R, Bradtke J, Reinhardt D, Stachel D, Metzler M
Journal article
A phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomas (2010)
Weidmann E, Hess G, Chow KU, Krause SW, Subklewe M, Kruse J, Weisel KC, et al.
Journal article